These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10380577)

  • 1. [Commitment and differentiation of osteoclast on stromal cells].
    Yamazaki H; Hayashi S
    Tanpakushitsu Kakusan Koso; 1999 Jun; 44(7):854-64. PubMed ID: 10380577
    [No Abstract]   [Full Text] [Related]  

  • 2. Commitment and differentiation of stem cells to the osteoclast lineage.
    Hayashi S; Yamane T; Miyamoto A; Hemmi H; Tagaya H; Tanio Y; Kanda H; Yamazaki H; Kunisada T
    Biochem Cell Biol; 1998; 76(6):911-22. PubMed ID: 10392705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal and spatial localization of osteoclasts in colonies from embryonic stem cells.
    Hemmi H; Okuyama H; Yamane T; Nishikawa S; Nakano T; Yamazaki H; Kunisada T; Hayashi S
    Biochem Biophys Res Commun; 2001 Jan; 280(2):526-34. PubMed ID: 11162550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
    Takahashi N
    Clin Calcium; 2006 Jun; 16(6):940-47. PubMed ID: 16751689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vital osteoclast: how is it regulated?
    Aeschlimann D; Evans BA
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S5-7. PubMed ID: 15243577
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
    Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E
    J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activin A is an essential cofactor for osteoclast induction.
    Fuller K; Bayley KE; Chambers TJ
    Biochem Biophys Res Commun; 2000 Feb; 268(1):2-7. PubMed ID: 10652202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis of bone marrow derived stem cells.
    Bayoumy M; Sankar U; Muthusamy N
    Indian J Exp Biol; 2002 Sep; 40(9):995-1000. PubMed ID: 12587726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction pathways regulating osteoclast differentiation and function.
    Tanaka S; Nakamura I; Inoue J; Oda H; Nakamura K
    J Bone Miner Metab; 2003; 21(3):123-33. PubMed ID: 12720046
    [No Abstract]   [Full Text] [Related]  

  • 10. The molecular basis of osteoclast differentiation and activation.
    Suda T; Kobayashi K; Jimi E; Udagawa N; Takahashi N
    Novartis Found Symp; 2001; 232():235-47; discussion 247-50. PubMed ID: 11277084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF.
    Sells Galvin RJ; Gatlin CL; Horn JW; Fuson TR
    Biochem Biophys Res Commun; 1999 Nov; 265(1):233-9. PubMed ID: 10548519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
    Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
    J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANKL-mediated osteoclast formation from murine RAW 264.7 cells.
    Collin-Osdoby P; Yu X; Zheng H; Osdoby P
    Methods Mol Med; 2003; 80():153-66. PubMed ID: 12728717
    [No Abstract]   [Full Text] [Related]  

  • 14. Activated T lymphocytes support osteoclast formation in vitro.
    Horwood NJ; Kartsogiannis V; Quinn JM; Romas E; Martin TJ; Gillespie MT
    Biochem Biophys Res Commun; 1999 Nov; 265(1):144-50. PubMed ID: 10548505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis.
    Abu-Amer Y; Abbas S; Hirayama T
    J Cell Biochem; 2004 Nov; 93(5):980-9. PubMed ID: 15389885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
    Gorny G; Shaw A; Oursler MJ
    Exp Cell Res; 2004 Mar; 294(1):149-58. PubMed ID: 14980510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration.
    Voronov I; Heersche JN; Casper RF; Tenenbaum HC; Manolson MF
    Biochem Pharmacol; 2005 Jul; 70(2):300-7. PubMed ID: 15919055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
    Ishida M; Amano S
    J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
    Merle B; Itzstein C; Delmas PD; Chenu C
    J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
    J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.